Log in

CVE:IBT - IBEX Technologies Stock Price, Forecast & News

-0.01 (-6.67 %)
(As of 02/23/2020 10:03 AM ET)
Today's Range
Now: C$0.14
50-Day Range
MA: C$0.13
52-Week Range
Now: C$0.14
Volume26,300 shs
Average Volume9,446 shs
Market CapitalizationC$3.47 million
P/E RatioN/A
Dividend YieldN/A
IBEX Technologies Inc., through its subsidiaries, manufactures and markets enzymes for biomedical use in Canada, the United States, the United Kingdom, and internationally. It offers a portfolio of recombinant glycosaminoglycan lyases, including Heparinase I, Heparinase II, Heparinase III, Chondroitinase AC, and Chondroitinase B. The company also manufactures and markets a range of arthritis assays, which are used in osteoarthritis research. In addition, it provides services, such as filling and lyophilization of diagnostic disposables for medical devices; and custom fermentation and purification of enzymes, as well as contract manufacturing. Further, the company makes and sells proteins extracted from botanicals. It serves manufacturers of medical devices, quality control labs, and academic research institutions. The company was founded in 1986 and is based in Montreal, Canada.

Industry, Sector and Symbol

Industry Biotechnology



Sales & Book Value

Annual SalesC$4.35 million
Cash FlowC$0.11 per share
Book ValueC$0.27 per share



Market CapC$3.47 million
Next Earnings Date3/27/2020 (Estimated)
OptionableNot Optionable

Receive IBT News and Ratings via Email

Sign-up to receive the latest news and ratings for IBT and its competitors with MarketBeat's FREE daily newsletter.

IBEX Technologies (CVE:IBT) Frequently Asked Questions

What is IBEX Technologies' stock symbol?

IBEX Technologies trades on the Canadian Venture Exchange (CVE) under the ticker symbol "IBT."

When is IBEX Technologies' next earnings date?

IBEX Technologies is scheduled to release their next quarterly earnings announcement on Friday, March 27th 2020. View Earnings Estimates for IBEX Technologies.

Has IBEX Technologies been receiving favorable news coverage?

Headlines about IBT stock have been trending somewhat negative recently, according to InfoTrie. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. IBEX Technologies earned a coverage optimism score of -1.3 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the stock's share price in the near future. View News Stories for IBEX Technologies.

Who are some of IBEX Technologies' key competitors?

What other stocks do shareholders of IBEX Technologies own?

Who are IBEX Technologies' key executives?

IBEX Technologies' management team includes the folowing people:
  • Mr. Paul Baehr, Pres, CEO & Chairman (Age 76)
  • Mr. Richard Collin, Director of Fin. & Sec.
  • Mr. Claire Bergeron, VP of Admin.

How do I buy shares of IBEX Technologies?

Shares of IBT and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is IBEX Technologies' stock price today?

One share of IBT stock can currently be purchased for approximately C$0.14.

How big of a company is IBEX Technologies?

IBEX Technologies has a market capitalization of C$3.47 million and generates C$4.35 million in revenue each year. View Additional Information About IBEX Technologies.

What is IBEX Technologies' official website?

The official website for IBEX Technologies is http://www.ibex.ca/.

How can I contact IBEX Technologies?

IBEX Technologies' mailing address is 5485 Pare St Suite 100, MONT-ROYAL, QC H4P 1P7, Canada. The company can be reached via phone at +1-514-3444004.

MarketBeat Community Rating for IBEX Technologies (CVE IBT)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  34 (Vote Outperform)
Underperform Votes:  50 (Vote Underperform)
Total Votes:  84
MarketBeat's community ratings are surveys of what our community members think about IBEX Technologies and other stocks. Vote "Outperform" if you believe IBT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IBT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel